Methods of producing molindone and its salts
US-8957206-B2 · Feb 17, 2015 · US
US11117862B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11117862-B2 |
| Application number | US-202016863020-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 30, 2020 |
| Priority date | Sep 14, 2012 |
| Publication date | Sep 14, 2021 |
| Grant date | Sep 14, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention is directed towards novel methods of synthesis of molindone, synthesis of the intermediates of molindone, and high-purity compositions of molindone. In particular, the invention relates to the methods of synthesis of molindone through the Mannich reaction.
Opening claim text (preview).
The invention claimed is: 1. A composition comprising molindone or its pharmaceutically acceptable salt as the sole active ingredient, formaldehyde, and 2,3-pentanedione-2,3-dioxime. 2. A composition comprising molindone or its pharmaceutically acceptable salt as the sole active ingredient, formaldehyde, 2,3-pentanedione-2,3-dioxime, and acetaldehyde oxime. 3. A composition comprising molindone or its pharmaceutically acceptable salt as the sole active ingredient and 2,3-pentanedione-2,3-dioxime. 4. A composition comprising molindone or its pharmaceutically acceptable salt as the sole active ingredient, 2,3-pentanedione-2,3-dioxime, and acetaldehyde oxime. 5. A composition comprising molindone or its pharmaceutically acceptable salt as the sole active ingredient, 2,3-pentanedione-2,3-dioxime, acetaldehyde oxime, and 1-hydroxy-propan-2-one oxime. 6. A composition comprising molindone or its pharmaceutically acceptable salt as the sole active ingredient and acetaldehyde oxime. 7. A composition comprising molindone or its pharmaceutically acceptable salt as the sole active ingredient, acetaldehyde oxime, and 1-hydroxy-propan-2-one oxime. 8. A composition comprising molindone or its pharmaceutically acceptable salt as the sole active ingredient and 1-hydroxy-propan-2-one oxime.
by reaction of hydroxylamines with carbonyl compounds · CPC title
with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring · CPC title
to an acyclic saturated chain · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.